| Scientific Name |
TOFACITINIB
|
|---|---|
| Brand Name |
Tofaci
|
| Risk |
Risk of venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), cardiovascular risk, myocardial infarction, herpes zoster, tuberculosis (TB), malignancy, gastrointestinal perforations, and lung disease.
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|